Daniel Gilbert

The decision by the Food and Drug Administration is expected to add to the demand for a new class of drugs transforming how patients battle obesity.

Novo Nordisk and Eli Lilly reported booming sales from their blockbuster diabetes and weight-loss drugs as both race to keep up with consumer demand.

Eli Lilly filed a complaint with the U.S. International Trade Commission to block companies from importing and selling cheaper versions of its hit drug Mounjaro.

Using brain implants, machine learning and a predictive model, researchers decoded a woman’s attempts to speak at a rate that begins to approach natural conversation.

Intas Pharmaceuticals in India made a widely used cancer drug in the U.S. An inspection exposed problems — and the fragility of the U.S. generic-drug supply.

Pfizer will move ahead with a pill version of a weight-loss drug as competition heats up for an oral medication that can rival Ozempic and other GLP-1 drugs.

Experimental devices implanted in a paralyzed man’s brain and spine communicate wirelessly and enhance his ability to walk and climb stairs, a paper in Nature found.

As ketamine has become increasingly popular as a mental health treatment, U.S. authorities have dramatically increased seizures of illicit forms of the drug, new research shows.

The U.S. government claims Gilead Sciences has made billions of dollars by capitalizing on an anti-HIV regimen patented by the CDC, while the drugmaker argues the patents are invalid.

It puts a spotlight on virtual prescribing and supply chain issues.